NeuroSense (NRSN) analyst forecast and price target
Analyst forecast
Consensus of 2 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| D. Boral Capital | Maintained | Buy | $14.00 | Apr 8, 2026 |
| D. Boral Capital | Maintained | Buy | $14.00 | Mar 25, 2026 |
| D. Boral Capital | Maintained | Buy | $14.00 | Mar 17, 2026 |
| Roth Capital | Initiated Coverage | Buy | $3.00 | Mar 10, 2026 |
| D. Boral Capital | Maintained | Buy | $14.00 | Mar 9, 2026 |
| D. Boral Capital | Maintained | Buy | $14.00 | Dec 22, 2025 |
| D. Boral Capital | Maintained | Buy | $14.00 | Nov 24, 2025 |
| D. Boral Capital | Maintained | Buy | $14.00 | Aug 15, 2025 |
| D. Boral Capital | Maintained | Buy | $14.00 | Jul 10, 2025 |
| D. Boral Capital | Initiated Coverage | Buy | $14.00 | May 12, 2025 |
| Maxim Group | Downgraded | Buy → Hold | — | Dec 16, 2024 |
| Alliance Global Partners | Initiated Coverage | Buy | $7.50 | Jul 17, 2023 |
Frequently asked questions
Is NRSN a buy, sell, or hold?
Analysts covering NeuroSense currently average a Buy rating: 2 buy, 0 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on NRSN?
On Apr 8, 2026, D. Boral Capital maintained NeuroSense at Buy with a price target of $14.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.